Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study was to assess the efficacy of the modified regimen short duration
intrapleural 16mg alteplase (Actilyse, Boehringer Ingelheim) with 5mg DNase (Pulmozyme
Hoffmann-La Roche Ltd) in patients with pleural infection.